Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 478.44M P/E - EPS this Y 22.10% Ern Qtrly Grth -
Income -35.38M Forward P/E -23.32 EPS next Y 78.00% 50D Avg Chg 16.00%
Sales 50.14M PEG -0.06 EPS past 5Y - 200D Avg Chg 64.00%
Dividend N/A Price/Book 30.87 EPS next 5Y 127.50% 52W High Chg -13.00%
Recommedations 2.10 Quick Ratio 7.35 Shares Outstanding 25.80M 52W Low Chg 328.00%
Insider Own 0.70% ROA -25.35% Shares Float 24.81M Beta 1.42
Inst Own 28.03% ROE -52.89% Shares Shorted/Prior 1.18M/590.73K Price 18.89
Gross Margin 84.48% Profit Margin -70.56% Avg. Volume 296,261 Target Price 25.80
Oper. Margin -86.46% Earnings Date May 13 Volume 93,726 Change -4.50%
About Avita Medical, Inc.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Avita Medical, Inc. News
04/15/24 AVITA Medical to Announce First Quarter 2024 Financial Results
04/10/24 AVITA Medical Updates Expected First Quarter 2024 Revenue
04/07/24 AVITA Medical (NASDAQ:RCEL) investors are sitting on a loss of 42% if they invested five years ago
03/17/24 This AVITA Medical Insider Increased Their Holding By 250% Last Year
02/29/24 AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
02/29/24 AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
02/25/24 AVITA Medical, Inc. (NASDAQ:RCEL) Just Reported And Analysts Have Been Lifting Their Price Targets
02/23/24 AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2023 Earnings Call Transcript
02/23/24 AVITA Medical to Host Investor Webinar Briefing
02/22/24 AVITA Medical Inc (RCEL) Reports Robust Revenue Growth in Q4 and Full-Year 2023
02/22/24 AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
02/07/24 AVITA Medical, Inc. (NASDAQ:RCEL): Are Analysts Optimistic?
02/01/24 AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
01/18/24 Institutional investors own a significant stake of 48% in AVITA Medical, Inc. (NASDAQ:RCEL)
01/10/24 AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
01/10/24 AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
01/04/24 AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
11/21/23 AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
11/20/23 AVITA Medical Updates Full Year 2023 Guidance
11/10/23 AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2023 Earnings Call Transcript
RCEL Chatroom

User Image bojak_2006 Posted - 1 day ago

$RCEL Earnings coming Tuesday, May 14th. I genuinely like this company. This used to be an $18 Stock back in February. Congrats on those who got in when it dropped between $8-$10. I think we will see it rally on Tuesday.

User Image stwit123 Posted - 04/29/24

$RCEL Medicare hates skin substitutes… Medicare say hello to RECELL !!! Or does Medicare hate RECELL too?

User Image TJmaximus Posted - 04/24/24

$RCEL boom

User Image TJmaximus Posted - 04/22/24

$RCEL $CVRX these are two pump and dump specials from @commoncentsinvestor

User Image MikeBravo7 Posted - 04/19/24

$RCEL Deja Vu all over again? EV3 shares continue fall as CEO resigns The Plymouth-based medical device maker's stock has fallen 40 percent over the past year. By Janet Moore Star Tribune APRIL 7, 2008 — 9:37PM Jim Corbett's resignation "was not the result of any disagreement," the company said. Shares of EV3 Inc. plunged 13 percent Monday after the Plymouth-based medical device company replaced its chief executive and cut first-quarter revenue guidance.

User Image scottgrant2 Posted - 04/18/24

$RCEL scam

User Image Fmello Posted - 04/17/24

$RCEL https://www.ktnv.com/news/unique-burn-treatment-helps-logandale-girl-recover-nearly-scar-free-at-las-vegas-hospital

User Image opgenopgen Posted - 04/16/24

$RCEL U.S. High Growth Tech and AI Stocks https://simplywall.st/discover/investing-ideas/215171/high-growth-tech-and-ai-stocks/us?via=bullmarketstocks

User Image Stock_Titan Posted - 04/15/24

$RCEL AVITA Medical to Announce First Quarter 2024 Financial Results https://www.stocktitan.net/news/RCEL/avita-medical-to-announce-first-quarter-2024-financial-ml3kkwclu7si.html

User Image Fullratio Posted - 04/12/24

$RCEL total assets is 80% greater than its total liabilities: https://fullratio.com/stocks/nasdaq-rcel/avita-medical

User Image pepe7 Posted - 04/12/24

$RCEL

User Image tradingtwenty Posted - 04/12/24

Top 5 oversold stocks that have trended in the past 24 hours: $ALLR 12.72🔥 $RCEL 17.05 $CPRI 18.79 $APVO 21.83 $DCFCQ 22.07 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image JHR Posted - 04/11/24

$RCEL

User Image TJmaximus Posted - 04/11/24

$RCEL https://seekingalpha.com/article/4675861-avita-medical-unconvincing-growth-amid-fierce-competition-burn-care-sector

User Image TJmaximus Posted - 04/11/24

$RCEL another @commoncentsinvestor special...careful of his pumps.

User Image zebbad Posted - 04/11/24

$RCEL what's the reason for the big drop off in share value? I'm attracted to red stocks. worth a little buy in I think.

User Image Fmello Posted - 04/11/24

$RCEL - Hopefully, they will get FDA approval for their ReCell Go device very soon.

User Image JHR Posted - 04/11/24

$RCEL When the nukes fall, this will skyrocket. I'm in! 600 shares at $10.05

User Image Roastingmarshmallows Posted - 04/11/24

$RCEL what caused this

User Image Fmello Posted - 04/11/24

$RCEL - Ouch! This is painful to watch. My stake is down 31k so far and it's not even noon yet.

User Image Lstreak Posted - 04/11/24

$RCEL They may take this down to nearly $9.00 today.

User Image IntrinsicTrader Posted - 04/11/24

$QQQ FAST $KMX $LOVE $PESI $RCEL GREAT EARNINGS! inflation is so low that people are buying loads and loads 😜 Won’t rest till Powell is indicted

User Image briefingcom Posted - 04/11/24

Gapping down: $LOVE -13.1% $RCEL -11.6% $PESI -9.9% $KMX -8.9% $FAST -5.1%

User Image TJmaximus Posted - 04/10/24

$RCEL no bueno

User Image DonCorleone77 Posted - 04/10/24

$RCEL Avita Medical backs FY24 revenue view $78.5M-$84.5M, consensus $80.09M "In light of the challenges encountered in the first quarter of 2024, we are intensifying our efforts to drive growth," said Jim Corbett, CEO of AVITA Medical. "While our account conversion rate impacted our quarterly revenue, we remain optimistic for the full year. With the recent launch of PermeaDerm in March and the upcoming launch of RECELL GO, along with our deeper understanding of the VAC processes and timelines, we believe that we will meet the lower end of our previously provided annual revenue guidance range of $78.5 million to $84.5 million. We remain committed to delivering value and making a positive impact on the lives of our patients."

User Image DonCorleone77 Posted - 04/10/24

$RCEL 2 of 2 - Avita Medical cuts Q1 commercial revenue view to $11M-$11.3M from $14.8M-$15.6M ....The slower-than-expected conversion rate is attributable to the complexity of closing a new account for a product that is approved for multiple indications. Despite this, the number of submissions active in the VAC process and robust prospecting pipeline continue to reflect significant potential for new account approvals, albeit at a slower approval pace than originally anticipated.

User Image DonCorleone77 Posted - 04/10/24

$RCEL 1 of 2 - Avita Medical cuts Q1 commercial revenue view to $11M-$11.3M from $14.8M-$15.6M Q1 revenue consensus $15.26M. The revision in guidance is attributable to a slower-than-expected conversion rate of new accounts for the expanded label of full-thickness skin defects. Since the launch of the full-thickness skin defects expanded label in June 2023 through the quarter ended March 31, 2024, AVITA Medical has added 73 new accounts, including 22 new accounts in the first quarter. In addition to the new accounts, there are 71 submissions in the evaluation or decision stage of the value analysis committee process as of March 31, 2024. However, the projected approval rate was 15 new accounts per month, for an expected total of 135 new accounts by March 31, 2024....

User Image Stock_Titan Posted - 04/10/24

$RCEL AVITA Medical Updates Expected First Quarter 2024 Revenue https://www.stocktitan.net/news/RCEL/avita-medical-updates-expected-first-quarter-2024-y8x683c078hp.html

User Image Task_Failed_Successfully Posted - 2 months ago

$RCEL

User Image TJmaximus Posted - 2 months ago

$RCEL https://seekingalpha.com/article/4675861-avita-medical-unconvincing-growth-amid-fierce-competition-burn-care-sector

Analyst Ratings
BTIG Neutral Apr 11, 24
Piper Sandler Overweight Feb 23, 24
Cantor Fitzgerald Overweight Feb 23, 24
Cantor Fitzgerald Overweight Jan 19, 24
Cantor Fitzgerald Overweight Nov 21, 23
Piper Sandler Overweight Nov 10, 23
Cantor Fitzgerald Overweight Oct 19, 23
Cantor Fitzgerald Overweight Sep 26, 23
Cantor Fitzgerald Overweight Aug 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
CORBETT JAMES CEO CEO Dec 26 Sell 13.29 1,445 19,204 11,580 12/27/23
COOK JEREMY CURNOCK Director Director Dec 21 Sell 12.49 2,500 31,225 20,614 12/22/23
O'Toole David D CFO CFO Nov 30 Buy 10.68 500 5,340 16,534 12/04/23
O'Toole David D CFO CFO Nov 14 Buy 13.07 2,000 26,140 11,000 11/15/23
Shiroma Donna General Counsel General Counsel Aug 21 Sell 15.84 4,193 66,417 42,257 09/08/23
O'Toole David D CFO CFO Aug 16 Buy 17.06 2,000 34,120 9,000 08/16/23
O'Toole David D CFO CFO Aug 15 Buy 17.93 5,000 89,650 7,000 08/15/23
O'Toole David D CFO CFO Jun 20 Buy 16.15 1,000 16,150 2,000 06/21/23
PERRY MICHAEL S Chief Executive Offi.. Chief Executive Officer Sep 16 Sell 27.21 47,861 1,302,298 425,087 09/16/20